Endocrine functions of the human heart have extensively been studied. Only recently, nucleotidergic mechanisms have been studied in detail. Therefore, an isolation strategy was developed to isolate novel nucleotide compounds from human myocardium. The human 
Introduction
The endocrine functions of myocardial tissue have widely been investigated in the past. Wellknown myocardium-derived hormonal factors include the atrial natriuretic peptide (1) or angiotensin II (2) . Except for the long-known nucleotide, ATP, new myocardium-derived nucleotides like diadenosine polyphosphates have only recently been isolated (3) .
As in myocardial tissue a great variety of nucleotidergic receptor subtypes (P1-and P2-receptors) are expressed (4, 5) , the secretion of nucleotides from myocardial cells represents one of the autocrine functions of the heart (6,7). In many studies it has been demonstrated that nucleotides exert numerous effects on cardiac functions (4, 5) . One of the important mechanisms of nucleotidergic signalling in the heart is the regulation of coronary perfusion.
A 2A receptors, P2X 1 receptors as well as P2Y 1 receptors contribute to the modulation of coronary vascular tone (6-11).
The present study aimed to extend our knowledge on autocrine loops in myocardial tissue. To this purpose, an isolation procedure was constructed, which is suitable to detect further novel nucleotides secreted by human myocardium. The experiments revealed adenosine 5'-tetraphosphate (Ap 4 ) in human myocardial tissue. Moreover, secretory granules contained this nucleotide, and studies in an animal model of coronary circulation revealed potent effects of Ap 4 on coronary vascular tone.
by guest on October 30, 2017 http://www.jbc.org/ Downloaded from 6 with 1 M ammonium acetate (pH 9.5). The pH of the eluate from the anion-exchange column was adjusted to pH 9.5 and loaded to the affinity column. The column was washed with 1 M ammonium acetate (pH 9.5) with a flow rate of 1 ml/min. Binding substances were eluted with 1 mM HCl. The eluate was frozen and lyophilized. Fractions were monitored with a UVdetector at 254 nm.
The fractions from the affinity-chromatography were desalted by reversed-phase highperformance liquid chromatography (HPLC) (Superspher 100 RP C18 endcapped, 250 x 4 mm, Merck) (step 7). The fractions dissolved in eluent A (40 mM TEAA) were injected to the HPLC. After a washing period of 10 min with eluent A the nucleotide-containing fraction was eluted with 30 % acetonitrile in water. The UV-absorbing fraction was collected.
The desalted fraction from the affinity chromatography was fractionated by an anion- The fractions from anion exchange chromatography were further separated by reversed-phase HPLC (Superspher 100 RP C18 endcapped, 250 x 4 mm, Merck) (step 9). The fractions dissolved in eluent A (40 mM TEAA) were injected to the HPLC. The following gradient was 7 programmed: 0-4 min 0 -2 % B, 4 -79 min 2 -7 % B, 79 -85 min 7 -60 %. The flow rate was 0.5 ml/min. The wavelength of the UV-detector was 254 nm. 1 ml fractions were collected.
Purification of adenosine 5'-tetraphosphate from porcine myocardial specific granules
Specific granules were obtained from porcine left ventricular tissue according to De Bold and Bencosme (14) . Briefly, immediately after sacrifice the heart was removed, washed in ice cold 0.25 M sucrose (containing 0,2 % glycogen, 1 mM EDTA, pH 7) and placed in a container with ice cold 0.25 M sucrose. After removing large vessels and fat, the tissue was washed for a second time in ice cold 0.25 M sucrose. After collecting 10 g myocardial tissue it was homogenized at 4 °C. The resulting pulp was washed into a glass homogenizer with 10 volumes of 0.25 M sucrose. The suspension was homogenized by 20 strokes of a Teflon pestle. The resulting homogenate was filtered by a cheesecloth. This filtrate was centrifuged at 1,900 g for 10 min. The supernatant was filtered again by a cheesecloth, at 1,900 g for 10 min, and centrifuged at 32,000 g for 10 min. The pellet containing specific granules was resuspended in 0.25 M sucrose and centrifuged again at 32,000 g for 10 min. The pellet was resuspended by addition of 4 ml 1.6 M sucrose (containing 0,2 % glycogen, 1 mM EDTA, pH 7). The remaining pellet was further resuspended by homogenizing in a glass homogenizer by a Teflon pestle. The suspension was pipetted on top of 0.5 ml of 2 M sucrose (containing 0,2 % glycogen, 1 mM EDTA, pH 7) and topped with 1 ml of 0.25 M sucrose. The resulting gradient was centrifuged immediately at 154,000 g for 60 min. After centrifugation 5 fractions were obtained. The protein concentration was measured according to Bradford (15) .
The fraction with less than 10% of the total protein amount contained the specific granules.
This fraction was collected, diluted to a 10-fold volume with water, and centrifuged at 32,000 g for 10 min.
MALDI-MS and PSD MALDI-MS
The molecular masses of the molecules in the fractions from reversed-phase HPLC (step 9)
were determined by matrix assisted laser desorption / ionization mass spectrometry (MALDI-MS). A reflectron type time-of-flight (RETOF) mass spectrometer, equipped with a nitrogenlaser (337 nm, pulse length 3 ns) was used for ion generation and mass analysis (12) . In MALDI-MS large fractions of the desorbed analyte ions undergo postsource decay (PSD) during flight in the field free drift path. Using a RETOF set-up, sequence information from PSD fragment ions of precursors produced by MALDI were obtained (16) . For MALDI-MS and PSD MALDI-MS speed-vacuum-dried samples were dissolved in 10 µl bidistilled water. 
UV-spectroscopy
The substances in the fractions of the reversed-phase HPLC (step 9), dissolved in 100 µl (pH 6.5), were analyzed by a UV-spectrometer (UV / Vis-Spectrophotometer, DU-600, Beckman).
The UV absorption was scanned from 400 nm to 190 nm with a scan speed of 400 nm/min.
Enzymatic cleavage experiments
Aliquots of the fractions from the reversed-phase column ( 
Isolated perfused heart
Isolated perfused rat hearts were taken from male Wistar-Kyoto rats aged 3 months weighing 250 -300 g and were prepared according to van der Giet et al.(11).
Responses of preparations to Ap 4, α,β-methyleneadenosine 5'-triphosphate (α,β-meATP), 2-methylthioadenosine 5'-triphosphate (2-meSATP), 2-chloroadenosine 5'-triphosphate (2-ClATP) were assessed at basal tone. For each substance dose-response curves were constructed, with 5 min being allowed to elapse between consecutive doses. This procedure allowed dose-response curves for several agonists to be constructed for the same preparation.
Desensitisation was not detected when 5 min were allowed to elapse between consecutive doses. Single doses of sodium nitroprusside (10 nmol) and acetylcholine (10 nmol) were used as controls for endothelium-independent or endothelium-dependent vasodilations mediated via NO.
Further experiments were done after endothelium was removed by Triton X-100 to investigate endothelium-independent effects of all used agonists. The endothelium was removed by perfusion of the isolated heart for 5 s with 0.1% Triton X-100. All monoadenosinephosphates, sodium nitroprusside and acetylcholine were applied as 100 µl bolus into a valve proximal to the preparation. Drug dilutions were performed daily from stock solutions of 10 mM (concentrates stores frozen in bidistilled water) with KrebsHenseleit-buffer unless indicated otherwise. Heparin (sodium salt), PPADS, MRS2179, α,β-meATP, 2-meSATP, 2ClATP were from Research Biochemicals Inc., Deisenhofen Germany.
Responses were measured as changes in perfusion pressure (mmHg) and results were presented as the means ± standard error of the mean (S.E.M.). Two-way repeated measures of variance, followed by Bonferroni's multiple comparison test (for changes in coronary perfusion pressure) were used to identify where statistically significant differences had occurred. The effects of L-NAME, MRS2179, PPADS, and α,β-meATP on coronary perfusion pressure were compared with drug-free control conditions using Mann-Whitney test. All P values presented are two-tailed. P values <0.05 were considered significant.
Results
Human ventricular myocardial tissue from transplant recipients was lyophilized and powdered (step 1). Homogenized powder was deproteinated by perchloric acid (step 2). Nucleotides were concentrated from the supernatant by reversed-phase chromatography (step 3). The concentrate was fractionated with size exclusion chromatography (step 4). The resulting chromatogram is presented in Figure 1A . Anionic substances with a molecular mass between 300 -2000 Da (indicated by solid line in Figure 1A ) were concentrated by an anion exchange HPLC (step 5). The resulting chromatogram is given in Figure 1B (Table 1 ). In table 1 the measured fragment ions of the fraction labeled in Figure 1C and of authentic AP 4 are listed together with an interpretation of the fragments. The above measurements therefore revealed a molecule containing adenosine together with 4 posphate moieties. In a further series of experiments the connection of the adenosine to the phosphate moieties was studied. To this purpose enzymatic cleavage experiments were done. 3'-exonuclease had no effect on the purified nucleotide, whereas alkaline phosphatase yielded AMP, ADP, and ATP. After incubation of the fraction with 5'-exonuclease, AMP was detected ( Figure 3) . The results suggest that in the molecule a chain of 4 phosphate groups is bound to adenosine via a 5'-phosphodiester bond.
In order to determine the localization of Ap 4 in ventricular myocardium, specific granules were examined for the presence of In isolated perfused rat heart experiments the mean coronary flow rate as measured in a total of 51 experiments amounted to 8.3±1.8ml/min to achieve a constant coronary perfusion pressure of 60±1mmHg. MRS2179 and PPADS did not significantly change vascular tone while L-NAME significantly (P<0.05) increased perfusion pressure. Permanent perfusion with α,β-meATP elicited a rapidly desensitizing vasoconstriction. 2) The findings reveal a profound dependence of Ap 4 's actions on endothelial integrity.
Ap 4 is a potent vasodilator in intact coronary vasculature. In the absence of endothelial P 2Y1 receptors, Ap 4 is a vasoconstrictor. This endothelium-dependent action may be relevant with respect to coronary pathology. It may be speculated that in severely atherosclerotic coronary vessels Ap 4 may be a mediator of vasospastic processes.
3)
The actions of Ap 4 are mediated by several of the known purinoceptor subtypes. The Ap 4 -induced vasconstriction depends on activation of an α,β-meATP sensitive, completely desensitizable P 2X -receptor subtype. Only mRNA for P 2X1 , P 2X2 and P 2X4 have been detected in coronary vasculature so far (26) . Additionally the P 2X5 -receptor was cloned in rat heart (27) .
In accordance with pertinent literature the P 2X2 -receptor and the P 2X5 -receptor are not activated by α,β-meATP (27, 28) . The P 2X4 -receptor cannot be inhibited by PPADS (29) . The P 2X1 -receptor is inhibitable by PPADS, sensitive to α,β-meATP and completely desensitizable (28) . Therefore it can be speculated the P 2X1 -receptor subtype is underlying the Ap 4 -induced vasoconstriction. P 2X -receptor subtypes are known to form hetero-oligomeric channels with new pharmacological properties. Among P 2X1 , P 2X2 , P 2X4 , P 2X5 , only P 2X1 and P 2X5 are reported to be able to assemble (30) . It cannot finally be excluded that a heterooligmeric form of P 2X1 and P 2X5 contributed to the Ap 4 -induced vasoconstriction in addition to the P 2X1 -receptor. On the other hand, the Ap 4 -induced vasodilation is mediated by the P 2Y1 -receptor subtype as evidenced by specific inhibition of P 2Y1 -receptor with MRS2179. From literature, it is known that P 2Y1 -receptors is expressed abundantly on endothelial cell surfaces, and therefore is responsible for the vasodilator action of Ap 4 (31) .
Beyond the isolation and characterization of Ap 4 , the experiments suggest that endogenous myocardium-derived nucleotides may be an important part of the spectrum of myocardial endocrine functions. Using the isolation procedure established in the present study, it will be possible to screen extracts from myocardiual tissue for further functionally relevant novel nucleotides. Since several other vasoactive nucelotides have been described in human myocardial tissue recently (3), the speculation may be allowed, that the group of myocardium-derived nucleotide hormones may be a larger and more complex family of extracellular messengers than was known in the last decades. (Fig 1 C) . From the characteristic fragmentation patterns, the structure of Ap 4 can be deduced. The left column, labeled fragment ions, shows the fragments that could be assigned to the masses obtained after fragmentation. M = Protonated parent ion. 
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